Top
image credit: Adobe Stock

Pfizer/BioNTech BA.4/BA.5 COVID-19 booster approved for emergency use by FDA in children five to 11 years

October 13, 2022

Via: PMLiVE
Category:

The bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein – present in the original Pfizer/BioNTech COVID-19 vaccine – together with mRNA encoding the spike protein of the Omicron BA.4/BA.5 subvariants. The booster has already been granted EUA by the FDA for ages 12 years and older.

The doses will be shipped immediately, pending recommendation from the Centers for Disease Control and Prevention (CDC), the companies outlined in a statement.

Read More on PMLiVE